Hc wainwright Invest Information

HC Wainwright Reaffirms Buy Rating for Pharming Group (PHAR) Mar 15, 2025

Zymeworks (NYSE:ZYME) Receives Neutral Rating from HC Wainwright Nov 1, 2024